title: Tasimelteon approved for circadian disorder in blind adults.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D001572:Benzofurans / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001766:Blindness / Q000150:complications*; D002940:Circadian Rhythm / Q000502:physiology; D003521:Cyclopropanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019388:Cytochrome P-450 CYP1A2 / Q000235:genetics; D006801:Humans; D044094:Receptors, Melatonin / Q000819:agonists*; D012893:Sleep Wake Disorders / Q000188:drug therapy* / Q000235:genetics
chemical_list: D001572:Benzofurans; D003521:Cyclopropanes; D044094:Receptors, Melatonin; C504573:CYP1A2 protein, human; D019388:Cytochrome P-450 CYP1A2; C478745:tasimelteon